Skip to main content
. 2022 Aug;32(Suppl 1):S1–S80.

Table 3.

Echocardiographic parameters at baseline and after 6 months of therapy with sac/val.

Baseline Follow-up P
Variables (n=132) (n=132)
LAVI,mL/m2 49.8 ±13.7 46.1 ± 12.0 0.001
LVEDV/BSA, mL/m2 89.6 ±9.8 87.8 ±8.4 <0.0001
LVESV/BSA, mL/m2 61.0 ±7.1 57.3 ± 5.9 <0.0001
LVEF, % 31.9 ± 1.4 34.7 ±1.6 <0.0001
CI mL/min/m2 1675.6 ±199.9 1856.6 ± 212.9 <0.0001
E/e' ratio 17.4 ±3.5 15.9 ±2.8 <0.0001
GLS, % -7.9 ±1.7 -9.0 ±1.4 <0.0001
RVOT, cm 2.6 ±0.4 2.1 ±0.4 <0.0001
RAA, cm2 20.5 ± 2.8 19.3 ± 2.3 <0.0001
TAPSE, mm 16.3 ±1.1 17.1 ±1.7 <0.0001
S-PAP, mmHg 44.5 ± 6.6 41.5 ±6.6 <0.0001
TAPSE/S-PAP, mm/mmHg 0.37 ± 0.06 0.42 ± 0.08 <0.0001
IVC, mm 20.2 ±1.3 19.1 ±3.3 <0.0001

Abbreviations: LAVI, left atrium volume index; LVEDV, left ventricular end-diastolic volume; BSA, body surface area; LVESV, left ventricular end-systolic volume; LYEF, left ventricular ejection fraction; CI, cardiac index; GLS, left ventricular global longitudinal strain; RVOT, right ventricular outflow tract; RAA, right atrium area; TAPSE, tricuspid annular plane excursion; S-PAP, systolic pulmonary arterial pressure; IVC, inferior vena cava.